. 2015 May 22;6(8):4756–4766. doi: 10.1039/c5sc00560d

Table 1. A list of phosphoproteins and their phosphorylation sites that show increased levels in lung cancer tissue compared to adjacent normal tissue ^a .

Acc. no	Gene name	Protein name	m/z	Charge	Modification site	303T/303N
Q13586	STIM1	Stromal interaction molecule 1	469.21	3	AEQS[Phospho (ST)]LHDLQER	12
P51858	HDGF	Hepatoma-derived growth factor	753.38	2	AGDLLEDS[Phospho (ST)]PKRPK	6
P00558	PGK1	Phosphoglycerate kinase 1	616.99	3	ALES[Phospho (ST)]PERPFLAILGGAK	25
P13796	LCP1	Plastin-2	615.76	2	EGES[Phospho (ST)]LEDLMK	11
P49736	MCM2	DNA replication licensing factor MCM2	987.41	2	GLLYDS[Phospho (ST)]DEEDEERPAR	12
Q9UKM9	RALY	RNA-binding protein Raly	579.31	2	GRLS[Phospho (ST)]PVPVPR	9
Q14004	CDC2L5	Cell division cycle 2-like protein kinase 5	505.93	3	ILELT[Phospho (ST)PEPDRPR	7
P37802	TAGLN2	Transgelin-2	680.28	2	NFS[Phospho (ST)]DNQLQEGK	7

^aThe T/N ratio for each peptide refers to the amount of phosphorylation in tumor tissue/amount of phosphorylation in adjacent normal tissue. The HDGF peptide is highlighted.

Table 1. A list of phosphoproteins and their phosphorylation sites that show increased levels in lung cancer tissue compared to adjacent normal tissue a .

Table 1. A list of phosphoproteins and their phosphorylation sites that show increased levels in lung cancer tissue compared to adjacent normal tissue ^a .